Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...

In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented ...

The treatment has been approved for NHS use, offering new hope to the nearly 12,000 people in England living with lupus ...

Water is often called the foundation of good health, yet meany people underestimate its impact when consumed at the right ...

SGLT2 inhibitors prevented age-related kidney damage in a rapid-aging fish. Treatment preserved blood vessels, energy ...

Johns Hopkins scientists and partners across the country are conducting research that could dramatically improve transplants, ...

NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.

Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for autosomal dominant polycystic kidney disease (ADPKD), the most common ...

What the research is about Our kidneys work tirelessly every day to filter our blood and keep it clean. They also ...

AstraZeneca's new formulation of systemic lupus erythematosus (SLE) therapy Saphnelo has been turned down by the FDA, despite getting the go-ahead in Europe a few weeks ago.

At Liv Hospital, specialists emphasize that stem cell therapy isn’t a one-size-fits-all solution. Instead, it is carefully indicated for specific diseases, patient profiles, and treatment ...